Torrent Pharma to manufacture and sell Pfizer’s Paxlovid generic
Torrent Pharmaceuticals Limited (TPL) has announced that it has signed a non-exclusive, non-transferable, non-sub licensable, license agreement to use the patents and... Read More
FDC launches Favipiravir oral suspension to treat mild to moderate cases of COVID-19
Pharma firm FDC Ltd on Monday said it has launched oral suspension of Favipiravir to treat mild to moderate cases of COVID-19... Read More
Covishield received emergency use authorization in India
Covidshield vaccine, developed by AstraZeneca and Oxford University has received for emergency use authorization in India. Drugs Controller General of India (DCGI)... Read More
Insight on Aurobindo and COVAXX exclusive licensing agreement
Aurobindo and COVAXX, have entered into an Exclusive License Agreement to develop, commercialize and manufacture Covid-19 Vaccine. Aurobindo Pharma and COVAXX, a... Read More
Pfizer, BioNTech covid vaccine approval tilldate
Pfizer, BioNTech covid vaccine (BNT162b2) has received following marketing authorization* approval till date. UK Bahrain Canada Mexico US Singapore Oman Saudi Arabia... Read More
Saudi Arabia signs non-binding vaccine agreement with CureVac
Saudi Arabia’s Pharmaceutical Industries and Medical supplies Corporation (Spimaco) signed a non-binding agreement with CureVac. CureVac is a German pharmaceutical company. CureVac... Read More
Pfizer submitted application for emergency use of Covid vaccine
US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government... Read More
MHRA UK inititated rolling review process of Moderna’s mRNA Covid-19 vaccine
Posted on30 Oct 2020
Comments0
Moderna, a biotechnology company, announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom has started the rolling... Read More
Insight on Veklury’s clinical and strategic pathway for USFDA approval for Covid-19
Posted on24 Oct 2020
TagsCOVID-19, priority review, Priority Review Designation, Remdesivir, usfda, usfda accelerated approval, USFDA Priority Review, Veklury
Comments0
USFDA approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at... Read More
FSD Pharma gets US FDA nod to begin phase 2 study of FSD201 to treat COVID-19
FSD Pharma announced that the US Food and Drug Administration (FDA) has authorized the initiation of a phase 2 study for the... Read More